Category Archives: Z Medical centers

BRAF and MEK combos for melanoma

Update October 1, 2015- The FDA approved the use of two drugs, Opdivo and Yervoy, to treat metastatic melanoma, as we first discussed with Dr.  Ribas last year.

Posted in - Biotech, - Pharma, Oncology, UCLA | Leave a comment

What is Justice Ruth Bader Ginsburg’s prognosis?

December 21, 2018- by Steven E. Greer, MD Supreme Court Justice Ruth Bader Ginsburd underwent surgery at Memorial Sloan Kettering

Posted in - Opinion, Cardiac surgery, Memorial Sloan-Kettering, Oncology | Leave a comment

Selective publication of positive trials on antidepressants

January 7, 2008- Interviewed and produced by Steven Greer, MD Erick Turner, MD, psychiatrist at Oregon Health and Science University and former FDA medical

Posted in Oregon Health and Science University, Psychology Psychiatry | Leave a comment

Catheter approaches for mitral replacement

March 23, 2014- interviewed by Steven E. Greer, MD With catheter based methods for replacing the aorta valve not being adopted as expected, the

Posted in - Medical Devices, Cardiac surgery, Cardiology, Henry Ford | Leave a comment

Atul Gawande’s surgical checklist fails in real world study

March 15, 2014- By Steven E. Greer, MD In 2009, Atul Gawande, MD, MPH and his large international team published in the New England

Posted in - Policy, General surgery, Harvard | Leave a comment

Google wants your medical records

December 19, 2013- Interviewed by Steven E. Greer, MD In Part 3 of our interview with Robert Klitzman, MD, ethics professor at Columbia University,

Posted in - Biotech, - Policy, Columbia, FDA, Genetics | Leave a comment

Apple, Google, and Amazon need to make their own hospitals

Update February 27, 2018- Well, they used my idea from two-years ago. Amazon, Warren Buffet,

Posted in - Medical Devices, - Opinion, CMS, Congress, Z Medical centers | Leave a comment

Brigham and Women’s Hospital engages in bizarre PR campaign for daily aspirin

 April 21, 2015- By Steven E. Greer, MD Brigham and Women’s Hospital in Boston, part of the Harvard University network of hospitals,

Posted in - Policy, Cardiology, Harvard, Neurology, Oncology | Leave a comment

Current surgical weight loss therapies

January 24, 2014- Interviewed by Steven E. Greer, MD Erik Dutson, MD, weight loss surgeon at UCLA, explains why his medical center does not implant the Lap-Band,

Posted in - Medical Devices, Bariatric surgery, General surgery, UCLA | Leave a comment

Don Berwick, MD: State health insurance exchanges

April 4, 2012

Posted in CMS, Congress, Harvard | Leave a comment

Don Berwick, MD: Changing from fee-for-service to bundled payments in Medicare and Medicaid

April 4, 2012

Posted in CMS, Harvard | Leave a comment

Don Berwick, MD: National Coverage Decisions

December 1, 2013- National Coverage Decisions (NCDs) are used by CMS to set guidelines as to

Posted in CMS, Harvard | Leave a comment

Don Berwick, MD: The Institute for Healthcare Improvement

Posted in CMS, Harvard | Leave a comment

Industry conflicts arise at PCORI threatening any real comparative effectiveness research

February 7, 2014- By Steven E. Greer, MD The Patient Centered Outcome Research Institute (PCORI) was created by the PPACA “ObamaCare” law in 2010.

Posted in - Medical Devices, - Opinion, - Pharma, CMS, Congress, Yale | Leave a comment

Review of immunotherapy and targeted therapy

June 17, 2016- interviewed by Steven E. Greer, MD We interviewed Siwen Hu-Lieskovan MD, PhD of UCLA, an expert with immunotherapies for melanoma, to go over the

Posted in - Biotech, - Pharma, Oncology, UCLA | Leave a comment

Insurance companies are not paying for Repatha and Praluent

Update November 2, 2018- Amgen slashed the annual cost of this drug to $6,000.

Posted in - Biotech, - Pharma, - Policy, Cardiac surgery, Cardiology, Henry Ford, Primary care medicine | Leave a comment

The Deans of Johns Hopkins and Miami discuss ACO’s

February 28, 2011- By Steven E Greer, MD Dean Miller of Johns Hopkins and Dean Goldschmidt of Miami discuss accountable care organizations,

Posted in - Policy, CMS, Johns Hopkins | Leave a comment

Ocrelizumab (Ocrevus) versus Placebo in Primary Progressive Multiple Sclerosis

January 31, 2017- Interviewed by Steven E. Greer, MD

Posted in - Biotech, - NEJM, - Pharma, Neurology, Univ Texas | Leave a comment

The Miami Summit on Healthcare Spending Reduction

June 29, 2010 Produced and interviewed by Steven Greer, MD The Healthcare Channel and The University of Miami Health System hosted a roundtable discussion

Posted in - Policy, CMS, Congress, Univ Miami | Leave a comment

Book Review: Fat Chance by Robert H. Lustig, MD

February 9, 2013- by Steven E. Greer, MD How did our ancient ancestors evolve from being pure meat eating carnivore hunters into grain fed

Posted in - Reviews, books, devices, Bariatric surgery, FDA, Gastroenterology and liver, Internal Medicine, Pediatrics, Primary care medicine, UC San Francisco | Leave a comment